0.68 - 0.75
0.33 - 0.86
18.34M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
26.24%
Revenue growth 1.25-1.5x 0259.HK's 19.26%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
9.27%
Gross profit growth under 50% of 0259.HK's 87.78%. Michael Burry would be concerned about a severe competitive disadvantage.
-4.45%
Negative EBIT growth while 0259.HK is at 243.57%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.45%
Negative operating income growth while 0259.HK is at 243.57%. Joel Greenblatt would press for urgent turnaround measures.
23.51%
Net income growth under 50% of 0259.HK's 186.47%. Michael Burry would suspect the firm is falling well behind a key competitor.
21.43%
EPS growth under 50% of 0259.HK's 184.62%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
21.43%
Diluted EPS growth under 50% of 0259.HK's 184.62%. Michael Burry would worry about an eroding competitive position or excessive dilution.
1.69%
Slight or no buybacks while 0259.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
1.59%
Slight or no buyback while 0259.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
19.78%
Positive OCF growth while 0259.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
25.16%
Positive FCF growth while 0259.HK is negative. John Neff would see a strong competitive edge in net cash generation.
21014.84%
10Y revenue/share CAGR above 1.5x 0259.HK's 152.81%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
24.65%
5Y revenue/share CAGR at 50-75% of 0259.HK's 48.18%. Martin Whitman would worry about a lagging mid-term growth trajectory.
-3.39%
Negative 3Y CAGR while 0259.HK stands at 6.72%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-9466.85%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-5313.50%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-1349.92%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
23.83%
Below 50% of 0259.HK's 2066.90%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-22.39%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
13.82%
Below 50% of 0259.HK's 551.03%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
95.36%
Positive 5Y equity/share CAGR while 0259.HK is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
40.98%
3Y equity/share CAGR at 50-75% of 0259.HK's 57.85%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
93.73%
Below 50% of 0259.HK's 899.96%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
84.64%
Below 50% of 0259.HK's 700.01%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
47.11%
AR growth well above 0259.HK's 35.12%. Michael Burry fears inflated revenue or higher default risk in the near future.
-21.61%
Inventory is declining while 0259.HK stands at 32.81%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
22.34%
Asset growth at 75-90% of 0259.HK's 25.59%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
4.73%
Under 50% of 0259.HK's 16.97%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
1816.96%
We have some new debt while 0259.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
80.16%
R&D growth of 80.16% while 0259.HK is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
47.97%
SG&A growth well above 0259.HK's 45.24%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.